ABSTRACT
OBJECTIVE: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. SUBJECTS AND METHODS: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the χ2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. RESULTS: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. CONCLUSION: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey.
Subject(s)
Lung Neoplasms/complications , Lung Neoplasms/psychology , Neoplasms, Squamous Cell , Palliative Care , Adult , Aged , Analgesics/therapeutic use , Comorbidity , Dyspnea/complications , Dyspnea/epidemiology , Fatigue/complications , Fatigue/epidemiology , Female , Humans , Interviews as Topic , Logistic Models , Lung Neoplasms/therapy , Male , Middle Aged , Neoplasm Staging , Pain/complications , Pain/epidemiology , Quality of Life , Turkey/epidemiologyABSTRACT
BACKGROUND: Sexually transmitted infection with the human papillomavirus (hpv) is responsible for a significant burden of human cancers involving the cervix, anogenital tract, and oropharynx. Studies in the United States and Europe have demonstrated an alarming increase in the frequency of hpv-positive oropharyngeal cancer, but the same direct evidence does not exist in Canada. METHODS: Using the London Health Sciences Centre pathology database, we identified tonsillar cancers diagnosed between 1993 and 2011. Real-time polymerase chain reaction was then used on pre-treatment primary-site biopsy samples to test for dna from the high-risk hpv types 16 and 18. The study cohort was divided into three time periods: 1993-1999, 2000-2005, and 2006-2011. RESULTS: Of 160 tumour samples identified, 91 (57%) were positive for hpv 16. The total number of tonsillar cancers significantly increased from 1993-1999 to 2006-2011 (32 vs. 68), and the proportion of cases that were hpv-positive substantially increased (25% vs. 62%, p < 0.002). Those changes were associated with a marked improvement in 5-year overall survival (39% in 1993-1999 vs. 84% in 2006-2011, p < 0.001). When all factors were included in a multivariable model, only hpv status predicted treatment outcome. INTERPRETATION: The present study is the first to provide direct evidence that hpv-related oropharyngeal cancer is increasing in incidence in a Canadian population. Given the long lag time between hpv infection and clinically apparent malignancy, oropharyngeal cancer will be a significant clinical problem for the foreseeable future despite vaccination efforts.
ABSTRACT
Amoebic keratitis is difficult to treat without total efficacy in some patients because of cysts, which are less susceptible than trophozoites to the usual treatments. The aim of this study is to evaluate the in vitro amoebicidal activity of the methanolic extracts of Satureja cuneifolia and Melissa officinalis. In the presence of methanolic extracts (ranging from 1.0 to 32.0 mg/ml), numbers of the viable Acanthamoe castellanii trophozoites and cysts were decreased during the experimental process. Both extracts showed a time- and dose-dependent amoebicidal action on the trophozoites and cysts. Among the extracts tested, S. cuneifolia showed the strongest amoebicidal effect on the trophozoites and cysts. In the presence of 32 mg/ml extract, no viable trophozoites were observed within 24 h. At the same concentration value, the extract was found effective against the cysts at a rate of 46.3% within 72 h of the experimental process. At 16 mg/ml extract concentration, no viable trophozoites were also observed in the 24th hour of the experiment. At the end of the experimental process, 34.7% of the cysts were killed by the extract. M. officinalis showed moderate amoebicidal effect. At the concentration of 32 mg/ml, 44.3% and 30.0% of the trophozoites and cysts were killed by the extract, respectively. Results obtained from these concentration values were found statistically different in terms of their actions both on trophozoites and cysts (p<0.05).
Subject(s)
Acanthamoeba castellanii/drug effects , Antiprotozoal Agents/pharmacology , Melissa/chemistry , Plant Extracts/pharmacology , Satureja/chemistry , Antiprotozoal Agents/isolation & purification , Dose-Response Relationship, Drug , Humans , Microbial Viability/drug effects , Plant Extracts/isolation & purification , Spores, Protozoan/drug effects , Time Factors , Trophozoites/drug effectsABSTRACT
Amebiasis is a severe illness caused by Entamoebachistolytica. The aim of this study is to evaluate the in vitro amebicidal activity of the rhizomes and aerial parts of Allium sivasicum, an endemic plant species from the flora of Turkey. Both extracts showed a time- and dose-dependent amebicidal action on the trophozoites. Among the extracts tested, rhizomes of A. sivasicum showed the strongest amebicidal effect on the trophozoites. In the presence of the rhizome extract at 2.0 mg/ml concentration, all of the trophozoites available in media have completely been killed within the 72nd hour. At 4.0 mg/ml extract concentration, all of the trophozoites available in media have completely been killed by the rhizome extract from the time of 24th hour. At 32.0 mg/ml extract concentration, 73.7% of the trophozoites were successfully killed by the extract within the first experimental hour. Aerial part extract at 4.0 mg/ml concentration completely killed the trophozoited within the 48th hour of the experimental procedure. At 8.0 mg/ml extract concentration, all of the trophozoites available in media have completely been killed by the aerial part extract from the time of 24th hour. At 32.0 mg/ml extract concentration, 67.7% of the trophozoites were successfully killed by the extract within the first experimental hour. These results suggest that the plant species evaluated here is a potential therapeutic drug for the treatment of Entamoeba infections, but it still needs to be evaluated quantitatively for determining the active phytochemicals.
Subject(s)
Allium/chemistry , Antiprotozoal Agents/pharmacology , Entamoeba histolytica/drug effects , Plant Extracts/pharmacology , Rhizome/chemistry , Antiprotozoal Agents/isolation & purification , Cell Survival/drug effects , Child, Preschool , Entamoeba histolytica/isolation & purification , Entamoebiasis/parasitology , Humans , Plant Extracts/isolation & purification , Time Factors , TurkeyABSTRACT
To enhance equity and diversity in undergraduate biology, recent research in biology education focuses on best practices that reduce learning barriers for all students and improve academic performance. However, the majority of current research into student experiences in introductory biology takes place at large, predominantly White institutions. To foster contextual knowledge in biology education research, we harnessed data from a large research coordination network to examine the extent of academic performance gaps based on demographic status across institutional contexts and how two psychological factors, test anxiety and ethnicity stigma consciousness, may mediate performance in introductory biology. We used data from seven institutions across three institution types: 2-year community colleges, 4-year inclusive institutions (based on admissions selectivity; hereafter, inclusive), and 4-year selective institutions (hereafter, selective). In our sample, we did not observe binary gender gaps across institutional contexts, but found that performance gaps based on underrepresented minority status were evident at inclusive and selective 4-year institutions, but not at community colleges. Differences in social psychological factors and their impacts on academic performance varied substantially across institutional contexts. Our findings demonstrate that institutional context can play an important role in the mechanisms underlying performance gaps.
Subject(s)
Academic Performance , Students , Humans , Learning , Minority Groups , UniversitiesABSTRACT
Nonpeptide agonists of each of the five somatostatin receptors were identified in combinatorial libraries constructed on the basis of molecular modeling of known peptide agonists. In vitro experiments using these selective compounds demonstrated the role of the somatostatin subtype-2 receptor in inhibition of glucagon release from mouse pancreatic alpha cells and the somatostatin subtype-5 receptor as a mediator of insulin secretion from pancreatic beta cells. Both receptors regulated growth hormone release from the rat anterior pituitary gland. The availability of high-affinity, subtype-selective agonists for each of the somatostatin receptors provides a direct approach to defining their physiological functions.
Subject(s)
Amides/pharmacology , Receptors, Somatostatin/agonists , Amides/metabolism , Amino Acid Sequence , Animals , Cell Line , Cells, Cultured , Cricetinae , Drug Design , Glucagon/metabolism , Growth Hormone/metabolism , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Ligands , Membrane Proteins , Mice , Models, Chemical , Molecular Sequence Data , Pituitary Gland, Anterior/drug effects , Pituitary Gland, Anterior/metabolism , Rats , Receptors, Somatostatin/physiologyABSTRACT
The Central European GNSS Research Network (CEGRN) collects GNSS data since 1994 from contributors which today include 42 Institutions in 33 Countries. CEGRN returns a dataset of coordinates and velocities computed according to international standards and the most recent processing procedures and recommendations. We provide a dataset of 1229 positions and velocities resulting from 3 or more repetitions of coordinate measurements of each site over 4 or more years. The velocity data result from a combination of eight multiyear, partially overlapping networks, using 234 stations of class A of the European Permanent Network (EPN) for alignment to the 'European Fixed' ETRF2000 Reference Frame. The rms (root mean square) of the 8 individual contributions to the combined solution, after a 7 - parameter Helmert transformation, is less than 5 mm in the observation period 1996-2017. This combined CEGRN network maintains the origin coincident with that of the ETRF2000 reference frame to within 1.8 mm rms for the entire period of analysis. The mean positions and velocities of common EPN Class A and CEGRN stations differ by 0.0 ± 1.1, 0.5 ± 1.0 and 0.1 ± 2.7 mm for the coordinates and 0.06 ± 0.13, -0.07 ± 0.12, 0.38 ± 0.28 mm/yr for the velocities respectively for the North, East and Up components at epoch 2010.0.
ABSTRACT
Moxalactam, a third-generation cephalosporin, has been demonstrated to have an ultrawide spectrum of antibacterial activity. One important gap in this impressive spectrum is the enterococcus. Superinfections and colonization with enterococci have been reported following moxalactam therapy. Sites involved have included the urinary tract, wounds, middle ear, and blood stream. To our knowledge, we report the first case of enterococcal liver abscess following moxalactam therapy. The abscess was localized by ultrasound examination and microbiologic diagnosis made by aspiration using a skinny needle. Without surgical drainage or therapeutic aspiration, institution of appropriate antibiotic therapy in optimum dosage resulted in complete resolution. The literature on enterococcal superinfections in association with moxalactam therapy and nonsurgical management of liver abscesses is reviewed.
Subject(s)
Cephalosporins/adverse effects , Cephamycins/adverse effects , Liver Abscess/chemically induced , Humans , Liver Abscess/diagnosis , Male , Middle Aged , MoxalactamABSTRACT
In June 1980, 23% of our Pseudomonas aeruginosa isolates and 53% of our Serratia species were resistant to gentamicin and tobramycin. During a 3 1/2-year period of almost exclusive amikacin usage, we noted a fall in overall resistance of gram-negative organisms to tobramycin and gentamicin from 18.8% and 19.3% to 15.2% and 16.2%, respectively. This fall in resistance was most notable for Escherichia coli, Proteus mirabilis, and Serratia species. During this period there was no increase in amikacin resistance. Age, hospitalization, prior antibiotic therapy, and Foley catheter use were predisposing factors in acquiring amikacin-resistant organisms. Amikacin-resistant gram-negative bacilli were usually sensitive to newer penicillins or cephalosporins.
Subject(s)
Amikacin/pharmacology , Gram-Negative Bacteria/drug effects , Kanamycin/analogs & derivatives , Age Factors , Aged , Amikacin/therapeutic use , Bacterial Infections/drug therapy , Catheterization/adverse effects , Drug Resistance, Microbial , Gentamicins/pharmacology , Gram-Negative Bacteria/isolation & purification , Hospital Bed Capacity, 500 and over , Hospitalization , Hospitals, Veterans , Humans , Microbial Sensitivity Tests , Middle Aged , Tennessee , Tobramycin/therapeutic useABSTRACT
In five years we studied 56 episodes of pneumococcal bacteremia. Twenty-three (41%) were nosocomial and 33 (59%) community acquired. Most of our patients were elderly men with multiple underlying diseases; however, those patients with nosocomial infections had a significantly higher incidence of malignant neoplasms (57% vs 24%), poor functional status (70% vs 25%), and ultimately fatal underlying disease (61% vs 21%). Alcoholism was more common among the patients with community-acquired bacteremia (45% vs 17%). Nosocomial infections carried a significantly higher overall mortality (73.9% vs 45.4%). The mortality directly related to the pneumococcal bacteremia was also higher (52% vs 39%), but not significantly. Most of the isolated strains were serotypes present in the new pneumococcal vaccine, which only one study patient had received. Mixed pneumococcal bacteremia with gram-negative bacilli was more frequent in nosocomial infections. Streptococcus pneumoniae can be a nosocomial pathogen in elderly, debilitated patients. Pneumococcal vaccination should be incorporated in a hospital-based prevention program for high-risk patients.
Subject(s)
Cross Infection , Pneumococcal Infections , Sepsis , Aged , Cross Infection/diagnosis , Cross Infection/microbiology , Cross Infection/therapy , Female , Humans , Male , Middle Aged , Pneumococcal Infections/diagnosis , Pneumococcal Infections/microbiology , Pneumococcal Infections/therapy , Sepsis/diagnosis , Sepsis/microbiology , Sepsis/therapy , Serotyping , Streptococcus pneumoniae/classificationABSTRACT
Group B streptococcal infections, although well studied in neonates, have only recently been appreciated as important infectious agents in adults. Seven cases of Group B streptococcal pneumonia were verified by transtracheal aspiration, blood and sputum cultures, or multiple stab cultures at autopsy. The infections were largely nosocomial and, ultimately, fatal in all seven patients. Our patients were older (average age, 73 years) and much more debilitated than the 13 cases reported in the literature. Diabetes was less common than previously reported. Previous antibiotic therapy was common. Concomitant isolation of another organism (especially Staphylococcus aureus) occurred in five patients. The morphologic findings at autopsy, in one patient, were characterized by a severely necrotizing destructive process. In our experience, Group B streptococcal pneumonia is more common, more devastating, and occurs in an older population than previously reported.
Subject(s)
Pneumonia/diagnosis , Streptococcal Infections/diagnosis , Adult , Aged , Humans , Lung/pathology , Male , Middle Aged , Pneumonia/etiology , Pneumonia/pathology , Streptococcal Infections/pathology , Streptococcus agalactiaeABSTRACT
A patient with multiple myeloma and a normal spleen died with high-grade pneumococcal bacteremia diagnosed by routine examination of a Wright-stained peripheral blood smear. In earlier reports, this finding has been described only in patients with abnormal or absent spleens. We review the proposed mechanisms of high-grade pneumococcal bacteremia in these patients and the immunologic abnormalities in patients with multiple myeloma that may result in increased susceptibility to this infection.
Subject(s)
Multiple Myeloma/complications , Pneumococcal Infections/blood , Sepsis/blood , Female , Humans , Middle Aged , Multiple Myeloma/blood , Pneumococcal Infections/diagnosis , Pneumococcal Infections/etiology , Sepsis/diagnosis , Sepsis/etiologyABSTRACT
Hospitalized and domiciliary patients were studied to determine the incidence of the endemic nematode Strongyloides stercoralls in stool samples. Strongyloides was found in 14 (6.1%) of 229 hospitalized patients and in nine (2.6%) of 346 domiciliary patients. Clinical symptoms, laboratory data, and underlying diseases were compared for stool-positive and stool-negative patients. Infected patients were more likely to complain of abdominal bloating. They had a higher incidence of eosinophilia and guaiac-positive stools. They were more likely to have been treated with corticosteroids, cimetidine, and antacids. Efficacy of treatment with thiabendazole was studied in all stool-positive patients; a relapse rate of 15% was noted with standard thiabendazole therapy.
Subject(s)
Strongyloidiasis/diagnosis , Aged , Hospitalization , Humans , Kentucky , Male , Middle Aged , North Carolina , Prospective Studies , Recurrence , Rural Population , Strongyloides/isolation & purification , Strongyloidiasis/drug therapy , Strongyloidiasis/epidemiology , Tennessee , Thiabendazole/therapeutic use , VirginiaABSTRACT
A man with IgG1 multiple myeloma developed fever, confusion, and progressive muscle weakness resulting in paralysis. Echovirus type 11 was isolated from cerebrospinal fluid, pleura, pleural fluid, and muscle, and muscle biopsy disclosed changes consistent with viral myositis. Immunologic evaluation revealed low serum levels of polyclonal IgG subtypes 1 and 3, reduced blood levels of T-helper/inducer and T-suppressor/cytotoxic cells, and a complement abnormality involving the function of the classical pathway C3 convertase, C4b2a. Therapy with intravenous immunoglobulin was associated with clinical recovery. This is the first reported case of disseminated central nervous system enteroviral infection in an adult with a B-cell malignancy, and in association with a documented complement abnormality. The findings suggest the efficacy of immunotherapy in this disease.
Subject(s)
Complement Activation , Echovirus Infections/etiology , Immunization, Passive , Multiple Myeloma/complications , Echovirus Infections/immunology , Echovirus Infections/therapy , Encephalitis/etiology , Humans , Immunoglobulin G/analysis , Leukocyte Count , Male , Middle Aged , Multiple Myeloma/immunology , Myositis/etiology , T-Lymphocytes , T-Lymphocytes, Helper-Inducer , T-Lymphocytes, RegulatoryABSTRACT
Nontypeable Haemophilus influenzae pneumonia occurred in 12 patients older than 60 years in a 15-month period. These patients represented approximately 11% of the 104 elderly patients with bacterial pneumonia in whom transtracheal aspiration was performed. Eighty-five percent of H influenzae isolates (12/14) recovered from elderly patients with pneumonia were nontypeable. Nontypeable H influenzae pneumonia occurred in the community, in nursing homes, and in the hospital. Patterns of both bilateral patchy bronchopneumonia and dense lobar consolidation were seen on chest roentgenograms.
Subject(s)
Haemophilus Infections/diagnosis , Pneumonia/diagnosis , Age Factors , Aged , Anti-Bacterial Agents/therapeutic use , Haemophilus Infections/drug therapy , Haemophilus Infections/mortality , Haemophilus influenzae/classification , Haemophilus influenzae/isolation & purification , Humans , Male , Middle Aged , Pneumonia/drug therapy , Pneumonia/mortalityABSTRACT
Bacterial pneumonia in the elderly is common, and causes more morbidity and mortality than in the younger adult. As patients live longer with more underlying disease and more iatrogenic disease, the incidence of nosocomial pneumonia will probably rise. Adequate sterilization of inhalation therapy equipment can reduce the risk of gram-negative nosocomial pneumonia. Methods to prevent colonization and microaspiration need to be investigated. The development of a gram-negative vaccine using Salmonella RE or E. coli J5 mutant would augur well for the future. Most important, the elderly patient with pneumonia should be managed promptly and aggressively in an attempt to determine the specific etiology of the pneumonia. The practice of antibiotic "shotgunning" of the elderly patient is to be avoided. Transtracheal aspiration or sheathed bronchoscopy can be performed if the patient is not able to produce sputum, or Gram stain is difficult to interpret. Morbidity and mortality can be reduced by early appropriate antibiotic therapy directed by Gram stain.
Subject(s)
Bacterial Infections/diagnosis , Pneumonia/etiology , Acinetobacter , Aged , Cross Infection/diagnosis , Enterobacteriaceae Infections/diagnosis , Escherichia coli Infections/diagnosis , Female , Haemophilus Infections/diagnosis , Humans , Klebsiella Infections/diagnosis , Legionnaires' Disease/diagnosis , Male , Middle Aged , Neisseriaceae , Pneumococcal Infections/diagnosis , Proteus Infections/diagnosis , Pseudomonas Infections/diagnosis , Serratia marcescens , Streptococcal Infections/diagnosisABSTRACT
Acinetobacter calcoaceticus var anitratus caused meningitis in five patients between 1968 and 1978 at two hospitals affiliated with Boston University School of Medicine. All patients had had head trauma or neurosurgical procedures prior to the development of meningitis. The course of the disease was relatively indolent in that fulminant disease did not occur even when initial therapy was inappropriate and bacteria persisted in CSF. All five patients survived. On Gram's stain of CSF, A calcoaceticus may be confused with meningococci, pneumococci, or Haemophilus influenzae and thus cause delay in appropriate diagnosis and therapy.
Subject(s)
Acinetobacter Infections/diagnosis , Meningitis/diagnosis , Postoperative Complications/diagnosis , Acinetobacter Infections/drug therapy , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Brain Diseases/surgery , Diagnosis, Differential , Female , Humans , Male , Meningitis/drug therapy , Middle AgedABSTRACT
ISG-15 is a 15-kDa protein encoded by an interferon (IFN)-stimulated gene (ISG), which is transcriptionally regulated by IFN-alpha and IFN-beta. Considered as part of the cytokine network, ISG-15 has the potential to amplify the immunomodulatory effects of these IFNs by enhancing IFN-gamma production, natural killer cell proliferation, and lymphokine-alphactivated killer cell cytotoxicity. To understand better the mechanism(s) of action of orally administered IFN-alpha, we have studied the effect of IFN-alpha on ISG-15 gene expression by human buccal epithelial cells (BEC). For in vitro studies, ISG-15 mRNA and protein levels were measured in BEC incubated for 0.5, 2, and 9 h with 100 or 1,000 IU/ml of human lymphoblastoid IFN-alpha. For in vivo studies, ISG-15 mRNA was measured in BEC samples collected at baseline, and 0.5, 2, and 9 h after 5-20 min of oral rinsing with 10 ml of IFN-alpha (1,000 IU/ml). ISG-15 mRNA was measured by reverse transcriptase polymerase chain reaction (RT-PCR), and ISG-15 protein production by Western Blot analysis. IFN-alpha augmented BEC ISG-15 gene expression in a concentration dependent manner both in vivo and in vitro. We conclude that orally administered IFN-alpha exerts its immunomodulatory effects in humans in part by upregulating the production of ISG-15 by BEC, thereby enhancing the immune reactivity of mucosa-associated lymphocytes.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Cytokines/genetics , Epithelial Cells/drug effects , Interferon-alpha/therapeutic use , Mouth Mucosa/drug effects , Transcription, Genetic , Ubiquitins/analogs & derivatives , Administration, Oral , Cell Division/drug effects , Cheek , Humans , In Vitro Techniques , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , Molecular Weight , Mouth Mucosa/cytology , Reverse Transcriptase Polymerase Chain Reaction , Stimulation, ChemicalABSTRACT
Aquaporins are a family of homologous membrane proteins that function as highly selective water channels. Aquaporin-5 (AQP5) is uniquely present in lacrimal and salivary glands, where it accounts for normal tear and saliva production. We tested the hypothesis that orally administered human interferon-alpha (HuIFN-alpha) benefits persons with xerostomia by augmenting the production of AQP5 protein by parotid gland epithelium. Cells from three human parotid glands were cultured with and without human lymphoblastoid IFN-alpha, and assayed for AQP5 mRNA levels by reverse transcriptase polymerase chain reaction (RT-PCR), and AQP5 protein levels by Western blot. Intracellular localization of AQP5 protein was done using confocal microscopy. The functional integrity of the glandular tissue was confirmed by RT-PCR analysis of alpha-amylase 1 and basic proline-rich protein transcripts. AQP5 was constitutively expressed in human parotid gland tissue, with AQP5 protein restricted to the plasma membranes and cytoplasmic vesicles of acinar cells. IFN-alpha augmented AQP5 transcription and protein production in a concentration-dependent manner, and increased the size of intensity of staining of AQP5-containing cytoplasmic vesicles in acinar cells. We conclude that IFN-alpha upregulates AQP5 gene expression in human parotid acinar cells in vitro. To our knowledge, this is the first demonstration that IFN-alpha regulates the gene expression of an aquaporin.
Subject(s)
Aquaporins/genetics , Interferon-alpha/therapeutic use , Membrane Proteins , Parotid Gland/drug effects , Administration, Oral , Aquaporin 5 , Cells, Cultured , Drug Evaluation, Preclinical , Gene Expression/drug effects , Humans , Male , Middle Aged , Parotid Gland/cytology , Parotid Gland/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Up-RegulationABSTRACT
Four blood isolates, 12 pneumonia isolates, and seven colonizing isolates of Branhamella catarrhalis were compared with respect to their ability to grow in normal human serum and in convalescent serum of a patient with B. catarrhalis bacteremia. Disease-causing isolates showed seven of 16 serum-resistant strains (43 percent) compared with one of seven (13 percent) colonizing strains. Bacteremic strains were not more serum-resistant than pneumonia-causing strains. Trypsin zones of inhibition were higher for disease-causing strains. There was no correlation between source of isolation and colistin sensitivity or ability to hemagglutinate red blood cells.